뉴스

• Antrogen Slides on Japan Fears, Hanmi Science Gains[K-Bio Pulse] South Korean biopharmaceutical stocks moved in opposite directions on Tuesday, with Antrogen tumbling to the daily limit on concerns over the commercial potential of its regenerative medicine product... www.edaily.co.kr · 2026.07.09